Join the top experts in the field in an interactive discussion to explore the role of GLP-1 RAs in the current landscape of incretin therapies for type 2 diabetes.
The webinar will consist of the following interactive parts:
• Part 1: Have diabetes goals changed? What is new and relevant to Diabetes Management – By Dr Abbas Raza (Pakistan)
• Part 2: GLP-1 Agonist: A closer look at role in Diabetes Management – by Dr David D’Alessio (USA)
• Part 3: Interactive Case (best practices/patient-centered approach) – by Dr Alvin Powers (USA)
• Part 4: Meet the Experts (Debate and Q&A)
---Moderation by Dr Boris Draznin (USA)---
After the webinar session, you will be invited to solve a CME-accredited case study on the ISE Global Education Hub to apply what you learned.
Supported by an educational grant from NOVO NORDISK A/S